Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01
Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders and schizophrenia.
Clinical Microbiomics A/S bags 10m financing
Danish microbiome specialist Clinical Microbiomics A/S has completed a 10m growth financing led by Seventure Partners.
EU starts largest study on factors affecting mental health
The EU Commission has granted £8.4m for Youth-GEMS, the largest ever study to identify genetic and other risks affecting mental health in adolescence.
Standing Ovation wins Industria Biotecs start-up pitch
French Standing Ovation has won the start-up pitch of Industria Biotec, held for the first time in Berlin. The event presents biotechnological solutions to save the climate.
Araris Biotech closes $24m Series A financing round
Swiss ADC maker Araris Biotech AG has added a $24m financing round to its CHF15.2m (S17.8m) seed round in 2020 to expand its portfolio of proprietary antibody drug conjugates.
New Protein Fund I supports 17 alternative protein start-ups
With money from its $50m New Protein Fund, Big Idea Ventures funds in 17 pre-seed plant-based, cell-based and microbial food, ingredient and technology companies.
Sibylla Biotech raises 23m Series A
Verona-based Sibylla Biotech has closed a 23m Series A financing round to advance its Pharmacological Protein Inactivation by Folding Intermediate Targeting (PPI-FIT) platform.
AI expert XUND GmbH bags 6m seed financing
Austrian XUND GmbH wants to use the assets of a 6m seed financing to grow in Germany, Switzerland and Austria.
ADC makeer Pheon Therapeutics raises $68m
Antibody-Drug Conjugate (ADC) specialist Pheon Therapeutics Ltd. has closed a $68m Series A financing co-led by Brandon Capital, Forbion and Atlas Venture.
Kupando raises 13m to push TLR4/7 agonist
Kupando has raised 13m in Series A financing co-led by Remiges Ventures and LifeCare Partners to initiate clinical development of KUP101.